Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 199.22M | 175.16M | 161.39M | 144.87M | 131.51M | 125.81M | 110.13M | 94.73M | 87.43M | 71.87M | 55.07M | 34.76M | 25.52M | 21.61M | 19.01M | 15.58M |
Cost of Revenue | 20.41M | 15.3M | 11.35M | 9.9M | 10.7M | 9.13M | 7.16M | 6.75M | 6.79M | 5.85M | 4.65M | 3.15M | 2.54M | 2M | 2.04M | 1.46M |
Gross Profit | 178.82M | 159.85M | 150.03M | 134.97M | 120.8M | 116.68M | 102.97M | 87.98M | 80.64M | 66.02M | 50.42M | 31.6M | 22.98M | 19.6M | 16.97M | 14.12M |
Operating Income | -29.2M | -38.85M | -27.72M | -20.95M | -34.1M | -29.71M | -47.18M | -48.39M | -47.41M | -55.63M | -87.92M | -72.66M | -86M | -77.32M | -69.14M | -53.22M |
Interest Income | 11.99M | 12.9M | 11.56M | 6.06M | 5.97M | 5.5M | 4.53M | 4.35M | 3.39M | 2.12M | 1.32M | 548K | 270.62K | 393K | 421K | 484K |
Pretax Income | -17.2M | -25.95M | -16.16M | -14.89M | -28.13M | -24.21M | -42.65M | -44.04M | -44.03M | -53.51M | -86.6M | -72.11M | -85.73M | -76.93M | -68.72M | -52.73M |
Net Income | -16.89M | -26.32M | -16.22M | -15.25M | -28.58M | -24.26M | -42.78M | -44.05M | -37.25M | -53.51M | -83.96M | -72.12M | -85.73M | -76.91M | -68.74M | -52.74M |
Selling & General & Admin | 137.73M | 132.1M | 121.57M | 113.08M | 104.72M | 105.21M | 101.01M | 98.92M | 94.63M | 88.38M | 100.32M | 75.46M | 79.68M | 70.5M | 69.85M | 52.58M |
Research & Development | 70.29M | 66.82M | 56.18M | 42.83M | 50.77M | 41.55M | 49.79M | 38.02M | 33.86M | 33.27M | 38.54M | 29.04M | 29.46M | 27.03M | 17.3M | 15.06M |
Other Expenses | n/a | -216K | n/a | n/a | n/a | n/a | n/a | -575K | -436K | n/a | -505K | -241K | -154.9K | -601.04K | -1.04M | -299.42K |
Operating Expenses | 208.01M | 198.7M | 177.76M | 155.92M | 154.9M | 146.39M | 150.14M | 136.37M | 128.06M | 121.65M | 138.35M | 104.26M | 108.98M | 96.93M | 86.11M | 67.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 92.2M | n/a | n/a | n/a | 85.8M | n/a | n/a | n/a | 82.5M | n/a | n/a | n/a |
Cost & Expenses | 228.42M | 214.01M | 189.11M | 165.82M | 165.6M | 155.52M | 157.31M | 143.12M | 134.84M | 127.5M | 143M | 107.42M | 111.52M | 98.93M | 88.15M | 68.8M |
Income Tax Expense | -317K | 374K | 57K | 359K | 448K | 43K | 135K | 10K | -6.77M | 1K | -2.64M | 5K | -541.23K | -23.13K | 23.76K | 5K |
Shares Outstanding (Basic) | 103.13M | 105.77M | 103.72M | 96.88M | 96.29M | 96.14M | 95.95M | 95.13M | 94.75M | 93.87M | 94.13M | 92.46M | 81.48M | 81.35M | 81.23M | 80.95M |
Shares Outstanding (Diluted) | 103.13M | 105.77M | 103.72M | 96.88M | 96.29M | 96.14M | 95.95M | 95.13M | 94.75M | 94.52M | 94.29M | 92.6M | 81.48M | 81.35M | 81.23M | 80.95M |
EPS (Basic) | 0.56 | -0.25 | -0.16 | -0.16 | -0.3 | -0.25 | -0.45 | -0.46 | -0.39 | -0.57 | -0.89 | -0.78 | -1.05 | -0.95 | -0.85 | -0.65 |
EPS (Diluted) | 0.56 | -0.25 | -0.16 | -0.16 | -0.3 | -0.25 | -0.45 | -0.46 | -0.39 | -0.57 | -0.89 | -0.78 | -1.05 | -0.95 | -0.85 | -0.65 |
EBITDA | -29.09M | -38.85M | -27.59M | -20.82M | -33.96M | -29.58M | -47.06M | -48.26M | -47.27M | -55.46M | -87.75M | -72.49M | -85.86M | -77.19M | -69.02M | -53.09M |
EBIT | -29.2M | -38.85M | -27.72M | -20.95M | -34.1M | -29.71M | -47.18M | -48.39M | -47.41M | -55.63M | -87.92M | -72.66M | -86M | -77.32M | -69.14M | -53.22M |
Depreciation & Amortization | 109K | 138K | 129K | 132K | 136K | 135K | 123K | 134K | 143K | 170K | 172K | 171K | 146.83K | 133.94K | 125.58K | 127.01K |